Email updates

Keep up to date with the latest news and content from Arthritis Research & Therapy and BioMed Central.

Meeting report

22nd European Workshop for Rheumatology Research, Leiden, The Netherlands, 28 February–3 March 2002

Andrew P Cope1* and Hendrik Schulze-Koops2

Author Affiliations

1 The Kennedy Institute of Rheumatology Division, Faculty of Medicine, Imperial College School of Science, Technology and Medicine, London, UK

2 Nikolaus Fiebiger Center for Molecular Medicine, University of Erlangen, Department of Medicine III, Erlangen, Germany

For all author emails, please log on.

Arthritis Res 2002, 4:276-279  doi:10.1186/ar418

Published: 14 May 2002

Abstract

The European Workshop for Rheumatology Research met this year in Leiden, The Netherlands. The Workshop provided a platform to feast on new technologies and how they have taken research programmes forward. While there will be the inevitable delay during which mechanisms are devised for analysing the huge amount of information generated by these technologies, there is a lot already to look forward to. Highlights included genomic, reverse genomic and proteomic approaches to understanding disease pathogenesis and to identifying new therapeutic targets. Opportunities for exploring whether pharmacogenomics has a place in the clinic are now a reality, and phage display technology has been applied to in vivo arthritis models to identify human synovial microvascular 'post codes'.

Keywords:
diagnostics; inflammation; prognostics; research; workshop